Dawn of a new era for treatment of Childhood TB

Dr Amitava Acharyya, CNS Correspondent, India
TB continues to be a major infectious disease among children.  Southeast Asia and Western Pacific regions are bearing more than 50% of the total childhood TB cases. India alone accounts for 27% of the global burden of paediatric TB. Nearly 5% of the new cases in India are reported among children. Early diagnosis and proper treatment plays a crucial role in not only improving cure rates but also in reducing the burden of drug sensitive as well as multi drug resistant TB (MDR-TB), the latter affecting 32,000 children globally.

[Call to register] Webinar for media in lead up to World Cancer Day 2016

[Webinar recording] We welcome you to register for an exclusive media webinar in lead up to this year's World Cancer Day 2016. Get connected with noted experts from lead agencies such as the Forum of International Respiratory Societies (FIRS)International Union Against Tuberculosis and Lung Disease (The Union), Union for International Cancer Control (UICC) - convener of World Cancer Day, Tata Memorial Cancer Hospital, leaders from Asia Pacific Lung Cancer Conference (APLCC 2016) and 70th National Conference of TB and Chest Diseases (NATCON 2016) secretariats, who will present and respond to questions live!

[Focus] A machine for vending sanitary napkins



A new year gift: Child friendly drugs to cure paediatric TB

Dr Richa Sharma, CNS Correspondent, India
TB has been known to mankind since ancient times and has claimed many lives every year since then. Children form a vulnerable category for many infections and TB is no different in this regard. According to the World Health Organization (WHO), 1 million children became infected with TB in 2014 and 140,000 died because of it. Yet children remain largely neglected in this regard.

Half the battle won with child-friendly TB drugs

Catherine Mwauyakufa, CNS Correspondent, Zimbabwe
We end the year 2015 with a sigh of relief for children as there has been a milestone achievement in TB treatment for children. A new and effective TB formulation for children has been unveiled. The world’s first appropriate child-friendly fixed dose combination (FDC) medicine to treat children with drug sensitive TB will soon be available in the market. This is bound to make medication, and hence treatment of childhood TB more manageable.

CNS Rewind 2015: Looking back to learn... and welcome 2016!